Canada / Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
AMERICAS
Digitalization / Puerto Rico: Harnessing Technology in Pharma Manufacturing
Three heads of manufacturing for big pharma affiliates in Puerto Rico elaborate on how digital technology is…
How US Healthcare Can Better Accommodate Cell & Gene Therapies
PhRMA’s Anne McDonald Pritchett PhD highlights the remarkable development of cell and gene therapies in…
Top 20 Pharma Companies in Puerto Rico
The top 20 pharmaceutical companies in Puerto Rico in the year leading up to December 2017 ranked by sales, with…
US Medicare Vows to Increase Payments for Cell & Gene Therapy
Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as…
R&D / Puerto Rico: A Clinical Trials Destination?
Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly…
Top 20 Drugs in the USA 2018
The bestselling drugs of 2018 in the USD 485 billion US pharma market. The list features several major blockbusters…
New York / A Biotech Hub to Rival Boston & California?
Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up.…
US Pharma Could do a Lot More to Embrace the Consumer
PwC’s Kelly Barnes examines how the US pharmaceutical sector is having to rethink its relationship with…
In Conversation
Michael Gorenstein, CEO, The Cronos Group, Canada
“If you are trying to be everything to everybody, you end up being nothing to no one”—Michael Gorenstein, CEO of The Cronos Group talks to PharmaBoardroom about his unusual career path, the company’s dual focus on medicinal and recreational cannabis, and how Canada will always remain the core center of IP development for the company. You just became the…
Pharma Faces
Ginette Petitpas Taylor
Minister | Health Canada
Mark Trudeau
President, CEO | Mallinckrodt
Mayra Guzman-Kaslow
President & CEO | GK Pharmaceuticals
Latest Reports
Focus on Mexico
The Ideal Pharma Country Manager: Mexico (Korn Ferry)
What traits, competencies and drivers do you need to be a successful pharma…
Fighting Corruption in Mexican Pharma
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma…
Read more from Mexico >>
Focus on Colombia
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Colombia: Ramping up the Local Footprint
With Latin America’s best healthcare system in terms of both coverage and…
Read more from Colombia >>
Focus on Puerto Rico
Did You Know? Medtech in Puerto Rico
Four top facts you may have missed about Puerto Rico's medical device…
Puerto Rico: Harnessing Technology in Pharma Manufacturing
Three heads of manufacturing for big pharma affiliates in Puerto Rico elaborate…
Read more from Puerto Rico >>
Focus on Canada
Collective Impact in the Health Charity Sector
Diabetes Canada's Jan Hux outlines how her organization has been able to shift…
Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents…
Read more from Canada >>
Focus on USA
Cybersecurity: A Health Business Risk Requiring Executive…
Carla Smith looks at the various cybersecurity risks that exist across the US…
ICER Strikes Again: Scandal Time?
The US drug-price watchdog, The Institute for Clinical & Economic Review…
Read more from USA >>
Focus on Brazil
Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil…
Why Pharma Needs Transformational Leaders
Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what…
Read more from Brazil >>
Legal Q&As
Patents & Trademarks: Ecuador
A structured legal guide about patents & trademarks in Ecuadorian Pharma. Prepared in association…
Preclinical and Clinical Trial Requirements: Argentina
Preclinical and clinical trial requirements in Argentina – a legal guide. Prepared in association with…
Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Panama
The low-down on the situation regarding cannabinoid drugs, medicinal cannabis and opioid drugs in Panama. Prepared…
New York / A Biotech Hub to Rival Boston & California?
Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up.…
A New Era in Access to Rare Disease Drugs in Canada
Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first…
A New Era for Puerto Rican Pharma Manufacturing? GK CMO Inaugurates $18.9…
GK CMO, a Puerto Rican contract manufacturing organization (CMO) recently inaugurated its manufacturing facility on…
Mexico’s Healthcare System: Perspectives from the Pharma Sector
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion…
5 Ways to Achieve a Sustainable US Health System
In the face of rising costs in American healthcare, Carla Smith outlines five ways in which the US can improve the…
“To Beat Diabetes, Governments Must Prioritise Patient Engagement”
Jan Hux, the president and CEO of Diabetes Canada calls for governments to place greater importance on partnerships…